Pricing Log in Create free account
Friday 6 November 2026 Export CYTK’s income statement to Excel — free account

Cytokinetics, Incorporated

CYTK Healthcare Biotechnology

Cytokinetics, Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $88.0 million, up 376.6% from fiscal 2024.

Revenue
+2,356.5%
EPS
+46.3%
Free cash flow
−6.73%
Total debt
−83.9%

Quarter to September 2026, against a year earlier

54.93 0.62 −1.12%
Market cap
$7.7B
P/E
0.0×
Fwd P/E
−10.3×
Dividend yield
—
F-score
2/9
Altman Z
−1.98
Beneish M
−0.44
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Cytokinetics, Incorporated (CYTK) Current ratio

Alert me on Current ratio

Cytokinetics, Incorporated's current ratio at the end of the quarter to 30 September 2026 was 3.4×, down 1.2× from fiscal 2025 (4.5×). Over the past ten years it has ranged from 3.6× (fiscal 2015) to 15.2× (fiscal 2020); the current reading is higher than 18% of that period. That is below the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 4.5× (26.55%)
FY2024 6.2× 0.81%
FY2023 6.1× (34.91%)
FY2022 9.4× 26.07%
FY2021 7.5× (50.96%)
FY2020 15.2× 69.22%
FY2019 9.0× (4.00%)
FY2018 9.4× 10.68%
FY2017 8.5× 77.25%
FY2016 4.8× 33.47%

Quarterly newest first

Period Current ratio Change
Sep 2026 3.4× (49.57%)
Jun 2026 6.7× 58.05%
Mar 2026 4.2× (6.95%)
Dec 2025 4.5× (34.13%)
43 more quarters

Against its own ten years

Low 3.6× High 15.2×
Ten-year median 7.5×
Current reading's percentile 18

Current ratio against peers

Company Current ratio
SYRE Spyre Therapeutics, Inc. compare 27.4×
PTGX Protagonist Therapeutics, Inc. compare 21.7×
KRYS Krystal Biotech, Inc. compare 7.9×
CAI Caris Life Sciences,�Inc. compare 6.7×
ARWR Arrowhead Pharmaceuticals, Inc. compare 5.9×
CYTK Cytokinetics, Incorporated 3.4×
MDGL Madrigal Pharmaceuticals, Inc. compare 3.1×
CORT Corcept Therapeutics Incorporated compare 3.0×
TWST Twist Bioscience Corporation compare 2.7×
Biotechnology industry median 4.9×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on CYTK